close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;139(Pt 5):1325-47.
doi: 10.1093/brain/aww050.

Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology

Affiliations
Review

Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology

John D Salamone et al. Brain. 2016 May.

Abstract

Motivation has been defined as the process that allows organisms to regulate their internal and external environment, and control the probability, proximity and availability of stimuli. As such, motivation is a complex process that is critical for survival, which involves multiple behavioural functions mediated by a number of interacting neural circuits. Classical theories of motivation suggest that there are both directional and activational aspects of motivation, and activational aspects (i.e. speed and vigour of both the instigation and persistence of behaviour) are critical for enabling organisms to overcome work-related obstacles or constraints that separate them from significant stimuli. The present review discusses the role of brain dopamine and related circuits in behavioural activation, exertion of effort in instrumental behaviour, and effort-related decision-making, based upon both animal and human studies. Impairments in behavioural activation and effort-related aspects of motivation are associated with psychiatric symptoms such as anergia, fatigue, lassitude and psychomotor retardation, which cross multiple pathologies, including depression, schizophrenia, and Parkinson's disease. Therefore, this review also attempts to provide an interdisciplinary approach that integrates findings from basic behavioural neuroscience, behavioural economics, clinical neuropsychology, psychiatry, and neurology, to provide a coherent framework for future research and theory in this critical field. Although dopamine systems are a critical part of the brain circuitry regulating behavioural activation, exertion of effort, and effort-related decision-making, mesolimbic dopamine is only one part of a distributed circuitry that includes multiple neurotransmitters and brain areas. Overall, there is a striking similarity between the brain areas involved in behavioural activation and effort-related processes in rodents and in humans. Animal models of effort-related decision-making are highly translatable to humans, and an emerging body of evidence indicates that alterations in effort-based decision-making are evident in several psychiatric and neurological disorders. People with major depression, schizophrenia, and Parkinson's disease show evidence of decision-making biases towards a lower exertion of effort. Translational studies linking research with animal models, human volunteers, and clinical populations are greatly expanding our knowledge about the neural basis of effort-related motivational dysfunction, and it is hoped that this research will ultimately lead to improved treatment for motivational and psychomotor symptoms in psychiatry and neurology.

Keywords: anergia; depression; dopamine; fatigue; reward.

PubMed Disclaimer

Figures

None
Motivation is critical for survival, and involves multiple behavioural functions mediated by a number of interacting neural circuits. Salamone et al . review basic neuroscience research, animal models, and clinical studies focused on brain mechanisms of effort-based decision making, and also consider the origins and treatment of motivational impairments in psychopathology.
Figure 1
Figure 1
Schematic showing anatomical connections in the rodent brain between structures involved in effort-related choice behaviour. Acb = nucleus accumbens; ACg = anterior cingulate gyrus; Amg = amygdala; DA = dopamine; GABA = gamma aminobutyric acid; Glut = glutamate; VP = ventral pallidum; VTA = ventral tegmental area.
Figure 2
Figure 2
Ability of methylphenidate and modafinil to reverse the effects of TBZ in rats responding on the concurrent FR5/chow choice task. All rats (adult male, Sprague-Dawley rats, Harlan Sprague-Dawley) were trained as described in Yohn et al. (2016 a ), and tested in 30-min sessions. Rats were tested 5 days/week, and drug testing was conducted 1 day each week, with a randomized order of drug treatments. ( A ) Methylphenidate. Rats ( n = 12) received intraperitoneal (IP) injections of vehicle or 0.75 mg/kg of TBZ 90 min prior to testing, and also received intraperitoneal injections of vehicle or methylphenidate 45 min prior to testing. Top : Mean [± standard error of the mean (SEM)] number of lever presses. There was an overall significant effect of drug treatment on lever pressing [ F (5,55) = 14.7, P < 0.001]. Planned comparisons showed that TBZ significantly decreased lever pressing compared to vehicle ( #P < 0.05), and that all doses of methylphenidate plus TBZ significantly increased lever pressing relative to TBZ plus vehicle ( **P < 0.01). Bottom : Mean (±SEM) gram quantity of chow intake. There was an overall significant effect of drug treatment on chow intake [ F (5,55) = 19.6, P < 0.001]. Planned comparisons showed that TBZ significantly increased chow consumption relative to vehicle ( #P < 0.05), and that all doses of methylphenidate plus TBZ significantly decreased chow intake relative to TBZ plus vehicle ( **P < 0.01). ( B ) Modafinil. Rats ( n = 12) received intraperitoneal injections of vehicle or 0.75 mg/kg of TBZ 90 min prior to testing, and intraperitoneal injections of either vehicle or modafinil 30 min prior to testing. Top : Mean (±SEM) number of lever presses. There was an overall significant effect of drug treatment on lever pressing [ F (5,55) = 21.0, P < 0.001]. Planned comparisons showed that TBZ significantly decreased lever pressing compared to vehicle ( #P < 0.05), and that the 7.5–30.0 mg/kg doses of modafinil plus TBZ significantly increased lever pressing relative to TBZ plus vehicle (* P < 0.05; **P < 0.01). Bottom : Mean (±SEM) gram quantity of chow intake. There was an overall significant effect of drug treatment on chow intake [ F (5,55) = 14.1, P < 0.001]. Planned comparisons showed that TBZ significantly increased chow consumption relative to vehicle ( #P < 0.05), and that the 7.5–30.0 mg/kg doses of modafinil plus TBZ significantly increased lever pressing relative to TBZ plus vehicle (* P < 0.05; **P < 0.01). Results are from the unpublished thesis of Augustyna Gojol, University of Connecticut, 2015.
Figure 3
Figure 3
The effect of increasing price, shown as ratio requirement, on the number of operant pellets consumed in rats with accumbens dopamine depletions compared to rats in the vehicle control group. These results are based on data from Aberman and Salamone (1999) . The data are represented as a demand curve, calculated from the mean number of reinforcement pellets consumed (shown on a log scale) as a function of price (ratio requirement). Although comparable levels of consumption in dopamine (DA)-depleted and control groups were seen with the FR1 schedule, dopamine-depleted rats showed markedly reduced consumption relative to the control group at higher ratio levels.

References

    1. Aberman JE, Ward SJ, Salamone JD. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive ratio performance . Pharmacol Biochem Behav 1998. ; 61 : 341 – 8 . - PubMed
    1. Aarts E, Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Cools R. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss . Neuroimage 2012. ; 59 : 3339 – 46 . - PubMed
    1. Aberman JE, Salamone JD. Nucleus accumbens dopamine depletions make animals more sensitive to high ratio requirements but do not impair primary food reinforcement . Neuroscience 1999. ; 92 : 545 – 55 . - PubMed
    1. Achterberg EJ, van Kerkhof LW, Servadio M, van Swieten MM, Houwing DJ, Aalderink M , et al. . Contrasting roles of dopamine and noradrenaline in the motivational properties of social play behavior in rats . Neuropsychopharmacology 2016. ; 41 : 858 – 68 . - PMC - PubMed
    1. Amsterdam JD, Settle RG, Doty RL, Abelman E, Winokur A. Taste and smell perception in depression . Biol Psychiatry 1987. ; 22 : 1481 – 5 . - PubMed

Publication types

MeSH terms